Guenin E - Search Results

1

Efficacy and Safety of Tazarotene 0.045% Lotion in Caucasian Adults With Moderate-to-Severe Acne.

Del Rosso J, Stein Gold L, Tyring S, Zeichner J, Callender V, Draelos Z, Werschler W, Cook-Bolden F, Guenin E. Del Rosso J, et al. Among authors: guenin e. J Drugs Dermatol. 2022 Oct 1;21(10):1061-1069. doi: 10.36849/JDD.6834. J Drugs Dermatol. 2022. PMID: 36219057 Clinical Trial.

2

Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.

Tyring SK, Kircik LH, Pariser DM, Guenin E, Bhatt V, Pillai R. Tyring SK, et al. Among authors: guenin e. J Drugs Dermatol. 2018 Oct 1;17(10):1084-1091. J Drugs Dermatol. 2018. PMID: 30365589 Clinical Trial.

3

Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris in a preadolescent population.

Eichenfield LF, Sugarman JL, Guenin E, Harris S, Bhatt V. Eichenfield LF, et al. Among authors: guenin e. Pediatr Dermatol. 2019 Mar;36(2):193-199. doi: 10.1111/pde.13744. Epub 2019 Jan 18. Pediatr Dermatol. 2019. PMID: 30656753 Free PMC article. Clinical Trial.

4

Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.

Cook-Bolden FE, Weinkle SH, Guenin E, Bhatt V. Cook-Bolden FE, et al. Among authors: guenin e. J Drugs Dermatol. 2019 Jan 1;18(1):32-38. J Drugs Dermatol. 2019. PMID: 30681791 Clinical Trial.

5

Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.

Kircik LH, Baldwin H, Lain E, Guenin E, Harris S, Bhatt V. Kircik LH, et al. Among authors: guenin e. J Drugs Dermatol. 2019 Feb 1;18(2):178-188. J Drugs Dermatol. 2019. PMID: 30811141 Clinical Trial.

6

Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety and tolerability in subgroups.

Harper JC, Roberts WE, Zeichner JA, Guenin E, Bhatt V, Pillai R. Harper JC, et al. Among authors: guenin e. J Dermatolog Treat. 2020 Mar;31(2):160-167. doi: 10.1080/09546634.2019.1587884. Epub 2019 Apr 2. J Dermatolog Treat. 2020. PMID: 30935257 Free article. Clinical Trial.

7

A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris.

Tanghetti EA, Kircik LH, Green LJ, Guenin E, Harris S, Martin G, Pillai R. Tanghetti EA, et al. Among authors: guenin e. J Drugs Dermatol. 2019 Jun 1;18(6):542. J Drugs Dermatol. 2019. PMID: 31251546 Clinical Trial.

8

Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.

Han G, Armstrong AW, Desai SR, Guenin E. Han G, et al. Among authors: guenin e. J Drugs Dermatol. 2019 Sep 1;18(9):910-916. J Drugs Dermatol. 2019. PMID: 31524347 Clinical Trial.

9

Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.

Lain E, Day D, Harper J, Guenin E. Lain E, et al. Among authors: guenin e. J Drugs Dermatol. 2019 Nov 1;18(11):1128-1138. J Drugs Dermatol. 2019. PMID: 31741356 Clinical Trial.

10

Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.

Harper JC, Baldwin H, Stein Gold L, Guenin E. Harper JC, et al. Among authors: guenin e. J Drugs Dermatol. 2019 Nov 1;18(11):1147-1154. J Drugs Dermatol. 2019. PMID: 31741360 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters